1. Germany Stocks

  2. •

    Basic Materials

  3. •

    Chemicals - Specialty
Lanxess AG

Lanxess AG

LNXSF
Lanxess AGUS flagOther OTC
20.80
USD
- -
- -
1.80BMarket Cap
Lanxess AG
LNXSF
(Other OTC)

Recent

price

20.80

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
85.58
105.47
109.3
99.76
90.49
86.34
84.12
71.35
74.56
77
70.49
70.66
93.67
77.76
73.73
- -
51.02
Revenue per Share
4.58
6.08
6.11
-1.91
0.53
1.8
2.1
0.95
4.71
2.32
10.22
3.09
2.9
5.13
-2.05
- -
-2.07
Basic EPS, GAAP
-0.85
-8.24
-6.66
-7.3
-4.87
-1.92
-2.07
5.15
1.14
1.53
1.49
-0.2
-2.87
5.93
2.18
- -
-1.09
Free Cash Flow per Basic Share
0.5
0.7
0.87
1
0.52
0.5
0.6
0.7
0.81
0.89
0.95
1
1.05
1.05
0.1
- -
0.12
Dividend per Share
15.24
1
7.1
-0.91
1.56
2.8
3.09
1.94
5.7
3.31
11.23
4.1
3.89
6.13
-1.05
- -
- -
Book Value per Share
18.45
20.44
23.32
18.95
20.81
22.1
35.34
17.8
11.02
9.98
15.61
14.2
12.69
20.68
23.87
- -
- -
Tangible Book Value per Share
83
83
83
83
88
92
92
92
92
88
87
86
86
86
86
86
86
Basic Weighted Avg Shares
7,120
8,775
9,094
8,300
8,006
7,902
7,699
6,530
6,824
6,802
6,104
6,101
8,088
6,714
6,366
- -
4,405
Sales/Revenue/Turnover
8.53
8.96
9.27
3.46
5.08
7.15
7.31
8.73
8.54
8.57
6.77
5.95
5.27
-0.74
0.79
- -
-1.82
Operating Margin (%)
283
325
378
717
426
418
481
410
415
503
504
457
546
996
566
- -
485
Depreciation Expense
381
506
508
-159
47
165
192
87
431
205
885
267
250
443
-177
- -
-179
Net Income, GAAP
22.72
22.6
22.88
- -
45
42.01
42.48
72.6
25.98
30.35
15.36
28.83
28.02
- -
- -
- -
- -
Effective Tax Rate (%)
5.35
5.77
5.59
-1.92
0.59
2.09
2.49
1.33
6.32
3.01
14.5
4.38
3.09
6.6
-2.78
- -
-4.06
Profit Margin (%)
1,477
1,300
2,142
1,337
1,507
1,079
3,725
1,499
2,382
2,148
2,235
2,010
2,424
1,735
1,676
- -
- -
Working Capital
- -
1,465
2,167
1,649
1,698
1,258
2,734
2,242
2,686
2,773
2,262
2,826
3,415
2,937
2,427
- -
- -
LT Debt
1,761
2,074
2,330
1,900
2,161
2,323
3,728
3,413
2,773
2,647
2,999
3,762
4,427
4,507
4,592
- -
- -
Total Equity
28.5
20.23
14.46
- -
5.34
7.91
6.01
2.39
7.16
7.23
6.08
3.91
3.82
- -
- -
- -
- -
Return on Invested Capital (%)
40.89
34.58
23.93
- -
5.36
11.7
8.19
1.96
11.29
9.25
27.46
8.47
7.44
- -
- -
- -
- -
Return on Capital (%)
34.68
74.91
150.74
- -
- -
83.76
71.24
37.74
123.14
50.37
140.03
40.27
72.46
102.43
- -
- -
- -
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Jun'25
Sep'25
Dec'25
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
86
86
- -
Market Capitalization
2,220
1,859
1,503

Working Capital

FRC

•

in mil. unless spec.
Jun'25
Sep'25
Dec'25
Total Current Assets
2,810
2,696
- -
Cash, Cash Equivalents & STI
625
606
- -
Accounts Receivable, Net
615
527
- -
Inventories
1,362
1,364
- -
Total Current Liabilities
1,167
1,035
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
- -
Free Cash Flow
- -
- -
- -
Net Income, GAAP
- -
- -
- -
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
1,899
1,778
1,601
1,436
6,714
2024
1,607
1,678
1,598
1,483
6,366
2025
1,601
1,466
1,338
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
-0.51
13.99
-1.52
- -
5.13
2024
-1.13
-0.19
0.01
- -
-2.05
2025
-0.66
-0.52
-0.89
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
1.05
- -
- -
1.05
2024
- -
0.1
- -
- -
0.1
2025
- -
0.12
- -
- -
- -
Similar Companies
Matex International Limited (M15.SI)
Umicore S.A. (UMI.BR)
Taiwan Hopax Chems.Mfg.Co.,Ltd. (6509.TWO)
Showa Chemical Industry Co., Ltd. (4990.T)
Borregaard ASA (BRRDF)
AksharChem (India) Limited (AKSCHEM.BO)
Business
Lanxess AG develops, manufactures and markets chemical intermediates, additives, specialty chemicals and consumer protection products worldwide. The company, headquartered in Cologne, Germany, and founded in 2004, operates through three segments: Advanced Industrial Intermediates, offering basic and fine chemicals, organometallics, salt, and inorganic pigments for construction materials, paints and coatings; Specialty Additives, providing additives for rubber, plastics, paints, construction and electrical industries including lubricants, flame retardants, plasticizers and bromine derivatives; and Consumer Protection, supplying disinfectants, hygiene and preservative solutions, flavors, fragrances, water treatment technologies, and precursors for agrochemicals, pharmaceuticals and specialty chemicals. Lanxess maintains approximately 11,800 employees across 32 countries with production sites, research centers and sales offices concentrated in Europe, North America, Asia-Pacific and Latin America, generating annual sales of EUR 6.4 billion in 2024. In recent strategic shifts, Lanxess completed the sale of its Urethane Systems business, comprising five global manufacturing sites and around 400 employees with EUR 265 million in estimated 2024 sales, to Japan's UBE Corporation on April 1, 2025, for gross proceeds of approximately EUR 500 million at an enterprise value of EUR 460 million, enabling redemption of its EUR 500 million benchmark bond maturing in May 2025 and reducing its leverage ratio to around 3x net financial debt to EBITDA pre. Additionally, on September 23, 2025, Lanxess exercised its contractual right to offer its entire 40.94% stake in Envalior GmbH, the engineering plastics joint venture formed in 2023 with DSM engineering materials and Advent International, to Advent for a base purchase price of approximately EUR 1.2 billion plus assumption of a EUR 200 million shareholder loan, subject to financing and targeting completion by April 1, 2026, as the final step in its portfolio transformation to a pure-play specialty chemicals company.

Company News

APIChat

  • seekingalpha.com

    LANXESS Aktiengesellschaft (LNXSY) Q1 2026 Earnings Call Transcript

  • seekingalpha.com

    LANXESS Aktiengesellschaft (LNXSY) Q4 2025 Press Conference Call Transcript

  • seekingalpha.com

    LANXESS Aktiengesellschaft (LNXSY) Q4 2025 Earnings Call Transcript

  • seekingalpha.com

    Oakmark International Small Cap Strategy Q3 2025 Top Contributors And Detractors

  • seekingalpha.com

    Lanxess' Q3: Down But Not Out

  • seekingalpha.com

    LANXESS Aktiengesellschaft (LNXSY) Q3 2025 Earnings Call Transcript

  • seekingalpha.com

    LANXESS Aktiengesellschaft (LNXSY) Q3 2025 Press Conference Call Transcript

  • seekingalpha.com

    Lanxess: The Best Anticyclical Bet You Can Make Right Now

  • seekingalpha.com

    Lanxess' Unsurprising Envalior Surprise Sale

  • seekingalpha.com

    LANXESS Aktiengesellschaft - Special Call

  • seekingalpha.com

    Lanxess Is Worth Another Look

  • seekingalpha.com

    LANXESS Aktiengesellschaft (LNXSF) Q2 2025 Earnings Call Transcript

  • seekingalpha.com

    LANXESS Aktiengesellschaft (LNXSF) Q1 2025 Earnings Call Transcript

  • seekingalpha.com

    LANXESS Aktiengesellschaft (LNXSF) Q4 2024 Earnings Conference Call Transcript

  • seekingalpha.com

    Lanxess Delivering On Self-Help, With Meaningful Leverage Potential When Volumes Recover

  • seekingalpha.com

    LANXESS Aktiengesellschaft (LNXSF) Q3 2024 Earnings Call Transcript

  • seekingalpha.com

    LANXESS Aktiengesellschaft (LNXSF) Q2 2024 Earnings Call Transcript

  • seekingalpha.com

    Lanxess May Finally See Some Light At The End Of The Tunnel

  • seekingalpha.com

    LANXESS Aktiengesellschaft (LNXSF) Q1 2024 Earnings Call Transcript

  • seekingalpha.com

    LANXESS Aktiengesellschaft (LNXSF) Q4 2023 Earnings Call Transcript